Chelsea M Kruse, MD | |
Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792-0001 | |
(563) 880-4962 | |
Not Available |
Full Name | Chelsea M Kruse |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | Uw Hospitals & Clinics 600 Highland Ave, Madison, Wisconsin |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033775606 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | FK0948527 (Wisconsin) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Chelsea M Kruse, MD Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792-0001 Ph: () - | Chelsea M Kruse, MD Uw Hospitals & Clinics 600 Highland Ave, Madison, WI 53792-0001 Ph: (563) 880-4962 |
News Archive
Higher blood pressure during exercise and delayed blood pressure recovery after exercise are associated with a higher risk of hypertension, preclinical and clinical cardiovascular disease and death among middle-aged to older adults.
The use of technology in medicine takes another step forward with a program being road-tested now at Creighton University Medical Center.
More than just causing discomfort, regional heatwaves have been associated with a number of health risks, particularly for children and the elderly.
In a recent commentary, We must face the threats, in the Journal of Neuroscience, researchers Dario Ringach and David Jentsch spoke out against animal rights extremism. They urged the scientific community to stand together and fight misconceptions about experiments using animals. That their plea has been heard is clear from the unanimously positive response it received on the Faculty of 1000 Biology website.
Repro-Med Systems, Inc., announced today that it has received approval from the Food and Drug Administration to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo RMS Subcutaneous Needle Sets.
› Verified 9 days ago